• 中国精品科技期刊
  • 《中文核心期刊要目总览》收录期刊
  • RCCSE 中国核心期刊(5/114,A+)
  • Scopus收录期刊
  • 美国《化学文摘》(CA)收录期刊
  • WHO 西太平洋地区医学索引(WPRIM)收录期刊
  • 《中国科学引文数据库(CSCD)》核心库期刊 (C)
  • 中国科技核心期刊
  • 中国科技论文统计源期刊
  • 《日本科学技术振兴机构数据库(中国)》(JSTChina)收录期刊
  • 美国《乌利希期刊指南》(UIrichsweb)收录期刊
  • 中华预防医学会系列杂志优秀期刊(2019年)

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

苏州市吴中区≥50岁成人重组带状疱疹疫苗知晓及接种意愿调查

张金华 段园园 曹丽娜 孙珏 李红美

张金华, 段园园, 曹丽娜, 孙珏, 李红美. 苏州市吴中区≥50岁成人重组带状疱疹疫苗知晓及接种意愿调查[J]. 中华疾病控制杂志, 2024, 28(9): 1030-1036. doi: 10.16462/j.cnki.zhjbkz.2024.09.007
引用本文: 张金华, 段园园, 曹丽娜, 孙珏, 李红美. 苏州市吴中区≥50岁成人重组带状疱疹疫苗知晓及接种意愿调查[J]. 中华疾病控制杂志, 2024, 28(9): 1030-1036. doi: 10.16462/j.cnki.zhjbkz.2024.09.007
ZHANG Jinhua, DUAN Yuanyuan, CAO Lina, SUN Jue, LI Hongmei. Investigation of awareness and vaccination willingness for recombinant zoster vaccine among 50 years adults in Wuzhong District, Suzhou[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(9): 1030-1036. doi: 10.16462/j.cnki.zhjbkz.2024.09.007
Citation: ZHANG Jinhua, DUAN Yuanyuan, CAO Lina, SUN Jue, LI Hongmei. Investigation of awareness and vaccination willingness for recombinant zoster vaccine among 50 years adults in Wuzhong District, Suzhou[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(9): 1030-1036. doi: 10.16462/j.cnki.zhjbkz.2024.09.007

苏州市吴中区≥50岁成人重组带状疱疹疫苗知晓及接种意愿调查

doi: 10.16462/j.cnki.zhjbkz.2024.09.007
详细信息
    通讯作者:

    李红美,E-mail: lihongmei@suda.edu.cn

  • 中图分类号: R752.1+2

Investigation of awareness and vaccination willingness for recombinant zoster vaccine among 50 years adults in Wuzhong District, Suzhou

More Information
  • 摘要:   目的   了解苏州市吴中区≥50岁成人对重组带状疱疹疫苗(recombinant zoster vaccine, RZV)的知晓、接种意愿率及其影响因素。   方法   从江苏省预防接种综合服务管理信息系统中导出苏州市吴中区长桥辖区≥50岁常住居民的相关数据,按照年龄分层(50~<60岁、60~<70岁、≥70岁)1∶15的比例,随机抽取1 267人纳入本研究,2022年8月采用电话询问方式开展问卷调查。计算RZV知晓及接种意愿率,采用logistic回归分析模型分析其影响因素。   结果   在1 147名研究对象中,男性516名(45.0%),女性631名(55.0%)。研究对象RZV知晓率为41.33%(n=474),接种意愿率为28.95%(n=332)。多因素logistic回归分析模型分析结果显示,年龄、职业、婚姻状况、家庭成员有带状疱疹(herpes zoster, HZ)既往史等是影响RZV知晓的主要因素。女性(OR=1.683, 95% CI: 1.234~2.296)、家庭成员中有医务人员(OR=1.778, 95% CI: 1.175~2.690)、关系密切的朋友中有医务人员(OR=1.956, 95% CI: 1.115~3.434)、HZ既往史(OR=1.944, 95% CI: 1.366~2.767)、家庭成员中有HZ既往史(OR=2.337, 95% CI: 1.698~3.218)、三价或四价流感病毒裂解疫苗(简称流感疫苗)接种史(OR=2.549, 95% CI: 1.813~3.582)、知晓RZV(OR=4.431, 95% CI: 3.235~6.069)是RZV接种意愿的促进因素(均P<0.05)。   结论   苏州市吴中区≥50岁成人RZV知晓率及接种意愿率均较低,女性、家庭成员中有医务人员、关系密切的朋友中有医务人员、自己或者家庭成员有HZ既往史等均是RZV接种意愿的促进因素。
  • 表  1  不同特征研究对象RZV知晓情况的比较

    Table  1.   Comparison of RZV awareness among participants with different characteristics

    变量Variable 总人数Total numberof people 知晓人数Number ofknown persons 知晓率Awarenessrate /% χ2值value P值value
    性别Gender 0.22 0.881
      男性Male 516 212 41.09
      女性Female 631 262 41.52
    年龄/岁Age / years 17.36 <0.001
      50~<60 418 203 48.56
      60~<70 461 160 34.71
      ≥70 268 111 41.42
    职业Career 45.91 <0.001
      非医务人员Non-medical personnel 1 065 411 38.59
      医务工作者Medical workers 82 63 76.83
    婚姻状况Marital status 6.29 0.012
      已婚 1 071 453 42.30
      未婚/离婚/丧偶Unmarried/divorce/widowed 76 21 27.63
    家庭成员中是否有医务人员Are there any medical personnel in the family 33.62 <0.001
      否No 187 113 60.43
      是Yes 960 361 37.60
    关系密切的朋友中是否有医务人员Whether there are medical personnel among close friends 57.08 <0.001
      否No 151 105 69.54
      是Yes 996 369 37.05
    水痘既往史History of varicella 9.95 0.007
      否或不清楚No or unclear 197 99 50.25
      是Yes 950 375 39.47
    HZ既往史History of herpes zoster 32.57 <0.001
      否No 236 136 57.63
      是Yes 911 338 37.10
    家庭成员HZ既往史History of herpes zoster in family members 82.87 <0.001
      否No 392 234 59.69
      是Yes 755 240 31.79
    流感疫苗接种史History of flu vaccination 12.94 0.003
      否No 384 187 48.70
      是Yes 763 287 37.61
    23价肺炎球菌多糖疫苗接种史History of pneumonia vaccine 23 9.68 0.019
      否No 280 138 49.29
      是Yes 867 336 38.75
    基础病史Basic medical history 5.03 0.377
      否No 552 223 40.40
      是Yes 595 251 42.18
    注:RZV,重组带状疱疹疫苗;HZ,带状疱疹。
    Note: RZV, recombinant zoster vaccine; HZ, herpes zoster.
    下载: 导出CSV

    表  2  不同特征研究对象RZV知晓情况的比较

    Table  2.   Comparison of RZV awareness among participants with different characteristics

    变量Variable 单因素Single factor 多因素Multiple factors
    OR值value(95% CI) P值value OR值value(95% CI) P值value
    性别Gender
      男性Male 1.000 1.000
      女性Female 1.018(0.804 ~ 1.290) 0.881 0.994(0.764 ~ 1.293) 0.964
    年龄/岁Age/years
      50~<60 1.000 1.000
      60~<70 0.563(0.429 ~ 0.738) <0.001 0.529(0.347 ~ 0.806) 0.003
      ≥70 0.749(0.549 ~ 1.021) 0.067 0.919(0.628 ~ 1.345) 0.664
    职业Career
      非医务人员Non-medical personnel 1.000 1.000
      医务人员Medical workers 5.276(3.113 ~ 8.943) <0.001 2.630(1.298 ~ 5.326) 0.007
    婚姻状况Marital status
      已婚Married 1.000 1.000
      未婚/离婚/丧偶Unmarried/divorce/widowed 0.521(0.311 ~ 0.874) 0.014 0.394(0.216 ~ 0.716) 0.002
    家庭成员中是否有医务人员Are there any medical personnel in the family
      否No 1.000 1.000
      是Yes 2.534(1.838 ~ 3.492) <0.001 1.571(1.079 ~ 2.289) 0.019
    关系密切的朋友中是否有医务人员Whether there are medical personnel among close friends
      否No 1.000 1.000
      是Yes 3.878(2.680 ~ 5.613) <0.001 1.936(1.160 ~ 3.233) 0.012
    水痘既往史History of varicella
      否或不清楚No or unclear 1.000 1.000
      是Yes 1.549(1.138 ~ 2.108) 0.005 1.016(0.695 ~ 1.487) 0.933
    HZ既往史History of herpes zoster
      否No 1.000 1.000
      是Yes 2.306(1.723 ~ 3.085) <0.001 2.132(1.541 ~ 2.948) <0.001
    家庭成员HZ既往史History of herpes zoster in family members
      否No 1.000 1.000
      是Yes 3.178(2.466 ~ 4.094) <0.001 3.249(2.447 ~ 4.314) <0.001
    流感疫苗接种史History of flu vaccination
      否No 1.000 1.000
      是Yes 1.574(1.229 ~ 2.017) <0.001 1.332(0.994 ~ 1.785) 0.055
    23价肺炎球菌多糖疫苗接种史History of pneumonia vaccine 23
      否No 1.000 1.000
      是Yes 1.536(1.171 ~ 2.014) 0.002 1.833(1.290 ~ 2.605) 0.001
    基础疾病病史Basic medical history
      否No 1.000 1.000
      是Yes 1.076(0.851 ~ 1.362) 0.539 1.032(0.769 ~ 1.384) 0.835
    注:RZV,重组带状疱疹疫苗;HZ,带状疱疹。
    Note: RZV, recombinant zoster vaccine; HZ, herpes zoster.
    下载: 导出CSV

    表  3  不同特征的研究对象RZV的接种率及未来接种愿意情况的比较

    Table  3.   Comparison of vaccination rate and future willingness of RZV among participants with different characteristics

    变量Variable 总人数Total numberof people 已接种人数Number ofvaccinatedpersons 接种率Vaccinationrate /% P值value 未来愿意接种人数Number of peoplewilling to be vaccinatedin the future 接种意愿率Vaccinationrate /% P值value
    性别Gender 0.001 0.001
      男性Male 516 43 8.33 123 23.84
      女性Female 631 93 14.74 209 33.12
    年龄/岁Age /years 0.004 <0.001
      50~<60 418 60 14.35 153 36.60
      60~<70 461 37 8.03 98 21.26
      ≥70 268 39 14.55 81 30.22
    职业Career 0.245 <0.001
      非医务人员Non-medical personnel 1 065 123 11.55 294 27.61
      医务人员Medical workers 82 13 15.85 38 46.34
    婚姻状况Marital status 0.273 0.999
      已婚Married 1 071 124 11.58 310 28.94
      未婚/离婚/丧偶Unmarried/divorce/widowed 76 12 15.79 22 28.95
    家庭成员中是否有医务人员Are there any medical professionals in your family 0.150 <0.001
      否No 187 28 14.97 90 48.13
      是Yes 960 108 11.25 242 25.21
    关系密切的朋友中是否有医务人员Whether there are medical personnel among close friends 0.099 <0.001
      否No 151 24 15.89 77 50.99
      是Yes 996 112 11.24 255 25.60
    水痘既往史History of varicella 0.017 <0.001
      否或不清楚No or unclear 197 31 15.74 82 41.62
      是Yes 950 105 11.05 250 26.32
    HZ既往史History of herpes zoster 0.007 <0.001
      否No 236 40 16.95 108 45.76
      是Yes 911 96 10.54 224 24.59
    家庭成员HZ既往史History of herpes zoster in family members <0.001 <0.001
      否No 392 75 19.13 179 45.66
      是Yes 755 61 8.08 153 20.26
    流感疫苗接种史History of flu vaccination <0.001 <0.001
      否No 384 73 19.01 163 42.45
      是Yes 763 63 8.26 169 22.15
    23价肺炎球菌多糖疫苗接种史History of pneumonia vaccine 23 <0.001 0.001
      否No 280 60 21.43 104 37.14
      是Yes 867 76 8.77 228 26.30
    是否知晓RZV Are you familiar with RZV <0.001 <0.001
      否No 474 133 28.06 239 50.42
      是Yes 673 3 0.45 93 13.82
    基础疾病病史Basic medical history 0.056 0.125
      否No 552 55 9.96 148 26.81
      是Yes 595 81 13.61 184 30.92
    注:RZV,重组带状疱疹疫苗;HZ,带状疱疹。
    Note: RZV, recombinant zoster vaccine; HZ, herpes zoster.
    下载: 导出CSV

    表  4  RZV未来接种愿意影响因素的logistic回归分析

    Table  4.   Logistic regression analysis of influencing factors of future willingness to RZV

    变量Variable 单因素Single factor 多因素Multiple factors
    OR值value(95% CI) P值value OR值value(95% CI) P值value
    性别Gender
      男性Male 1.000 1.000
      女性Female 1.582(1.218~2.056) 0.001 1.683(1.234~2.296) 0.001
    年龄/岁Age/years
      50~<60 1.000 1.000
      60~<70 0.468(0.347~0.631) <0.001 0.478(0.294~0.777) 0.003
      ≥70 0.750(0.540~1.041) 0.086 1.111(0.707~1.744) 0.648
    职业Career
      非医务人员Non-medical personnel 1.000 1.000
      医务人员Medical workers 2.265(1.438~3.568) <0.001 0.558(0.271~1.149) 0.113
    家庭成员中是否有医务人员Are there any medical professionals in your family
      否No 1.000 1.000
      是Yes 2.753(1.995~3.798) <0.001 1.778(1.175~2.690) 0.006
    关系密切的朋友中是否有医务人员Whether there are medical personnel among close friends
      否No 1.000 1.000
      是Yes 3.024(2.132~4.288) <0.001 1.956(1.115~3.434) 0.019
    婚姻状况Marital status
      已婚Married 1.000 1.000
      未婚/离婚/丧偶Unmarried/divorce/widowed 1.000(0.599~1.671) 1.000 1.048(0.548~2.003) 0.887
    水痘既往史History of varicella
      否或不清楚No or unclear 1.000 1.000
      是Yes 1.997(1.453~2.745) <0.001 1.288(0.853~1.945) 0.229
    HZ既往史History of herpes zoster
      否No 1.000 1.000
      是Yes 2.588(1.923~3.484) <0.001 1.944(1.366~2.767) <0.001
    家庭成员HZ既往史History of herpes zoster in family members
      否No 1.000 1.000
      是Yes 3.307(2.533~4.316) <0.001 2.337(1.698~3.218) <0.001
    流感疫苗接种史History of flu vaccination
      否No 1.000 1.000
      是Yes 2.592(1.989~3.378) <0.001 2.549(1.813~3.582) <0.001
    23价肺炎疫苗接种史History of pneumonia vaccine 23
      否No 1.000 1.000
      是Yes 1.656(1.245~2.204) 0.001 1.381(0.911~2.092) 0.128
    是否知晓RZV Are you familiar with RZV
      否No 1.000 1.000
      是Yes 6.342(4.777~8.421) <0.001 4.431(3.235~6.069) <0.001
    基础疾病病史Basic medical history
      否No 1.000 1.000
      是Yes 0.818(0.633~1.057) 0.125 0.729(0.516~1.030) 0.073
    注:RZV,重组带状疱疹疫苗;HZ,带状疱疹。
    Note: RZV, recombinant zoster vaccine; HZ, herpes zoster.
    下载: 导出CSV
  • [1] 邓慧杰, 刘芳勋. 我国带状疱疹流行病学特征及疫苗免疫规划研究进展综述[J]. 中国继续医学教育, 2021, 13(19): 135-138. DOI: 10.3969/j.issn.1674-9308.2021.19.039.

    Deng HJ, Liu FX. Epidemiological characteristics of herpes zoster and research progress of vaccine immunization program in China[J]. Chin Cont Med Edu, 2021, 13(19): 135-138. DOI: 10.3969/j.issn.1674-9308.2021.19.039.
    [2] 王官清, 李晓霞. 带状疱疹的临床流行病学及预防[J]. 中国皮肤性病学杂志, 2018, 32(11): 1325-1330. DOI: 10.13735/j.cjdv.1001-7089.201801079.

    Wang Guanqing, Li Xiaoxia. Clinical Epidemiology and Prevention of Herpes Zoster[J]. Chinese Journal of Dermatovenereology, 2018, 32(11): 1325-1330. DOI: 10.13735/j.cjdv.1001-7089.201801079.
    [3] 中国医疗保健国际交流促进会皮肤科分会, 中华医学会皮肤性病学分会老年性皮肤病研究中心. 带状疱疹疫苗预防接种专家共识[J]. 中华医学杂志, 2022, 102(8): 538-543. DOI: 10.3760/cma.j.cn112137-20210828-01958.

    China Healthcare International Exchange and Promotion Association Dermatology Branch, Chinese Medical Association Dermatology and Venereology Branch Center for Research on Aging Skin Diseases. Expert consensus on vaccination against herpes zoster[J]. Natl Med J Chin, 2022, 102(8): 538-543. DOI: 10.3760/cma.j.cn112137-20210828-01958.
    [4] Wang YF, Qi JL, Cao H, et al. Immune responses to Varicella-zoster virus glycoprotein E formulated with poly(lactic-co-glycolic acid) nanoparticles and nucleic acid adjuvants in mice[J]. Virol Sin, 2021, 36(1): 122-132. DOI: 10.1007/s12250-020-00261-y.
    [5] Lu L, Suo L, Li J, et al. A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China[J]. Hum Vaccin Immunother, 2018, 14(11): 2632-2635. DOI: 10.1080/21645515.2018.1489193.
    [6] 席艳君, 王叶子, 吴晓冰, 等. 区域医联体内≥50岁医务人员带状疱疹疫苗接种意愿及影响因素分析[J]. 社区医学杂志, 2019, 17(23): 1468-1472. DOI: 10.19790/j.cnki.JCM.2019.23.04.

    Xi YJ, Wang YZ, Wu XB, et al. Analysis of willingness and influencing factors of herpes zoster vaccination among medical workers aged 50 or over in regional medical association[J]. J Community Med, 2019, 17(23): 1468-1472. DOI: 10.19790/j.cnki.JCM.2019.23.04.
    [7] Maltz Fraidy, Fidler Brooke. Shingrix: a new gerpes zoster vaccine[J]. PT, 2019, 44(7): 406-433. DOI: 10.1056/NEJMcp1302674.
    [8] 陆佳, 陆昕悦, 沈钰涛, 等. 上海市闵行区50岁以上人群流感、肺炎、带状疱疹疫苗接种意愿及其相关因素分析[J]. 中华预防医学杂志, 2022, 56(2): 125-131. DOI: 10.3760/cma.j.cn112150-20210423-00406.

    Lu J, Lu XY, Shen YT, et al. Analysis of influenza, pneumonia and herpes zoster vaccination willingness and related factors among people over 50 years old in Minhang District, Shanghai[J]. Chin J Prev Med, 2022, 56(2): 125-131. DOI: 10.3760/cma.j.cn112150-20210423-00406.
    [9] 仇静, 孙晓冬, 胡家瑜, 等. 2020年5-6月上海市≥50岁成人带状疱疹疫苗接种意愿调查[J]. 中国疫苗和免疫, 2021, 27(3): 307-310, 327. DOI: 10.19914/j.CJVI.2021057.

    Qiu J, Sun XD, Hu JY, et al. Willingness to receive herpes zoster vaccine and factors influencing willingness among≥50-year-old adults of Shanghai in May-June 2020[J]. Chinese Journal of Vaccines and Immunization, 2021, 27(3): 307-310, 327. DOI: 10.19914/j.CJVI.2021057.
    [10] 黄淑雅, 宋静卉, 邢丽媛. 郑州地区50岁居民带状疱疹疫苗接种意愿及影响因素调查[J]. 华南预防医学, 2022, 48(6): 752-755. DOI: 10.12183/j.scjpm.2022.0752.

    Huang SY, Song JH, Xing LY. Investigation on herpes zoster vaccination willingness and influencing factors among residents aged 50 years and over in Zhengzhou area[J]. South China J Prev Med, 2022, 48(6): 752-755. DOI: 10.12183/j.scjpm.2022.0752.
    [11] Aguilar-Diaz FC, Jimenez-Corona ME, Ponce-de-Leon-Rosales S. Influenza vaccine and healthcare workers[J]. Arch Med Res, 2011, 42(8): 652-657. DOI: 10.1016/j.arcmed.2011.12.006.
    [12] Weinberger B. Vaccination of older adults: influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond[J]. Immun Ageing, 2021, 18(1): 38. DOI: 10.1186/s12979-021-00249-6.
    [13] Yue M, Wang Y, Low CK, et al. Optimal design of populationlevel financial incentives of influenza vaccination for the elderly[J]. Value Health, 2020, 23(2): 200208. DOI: 10.1016/j.jval.2019.08.006.
  • 加载中
表(4)
计量
  • 文章访问数:  60
  • HTML全文浏览量:  13
  • PDF下载量:  11
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-11-07
  • 修回日期:  2024-04-19
  • 网络出版日期:  2024-10-24
  • 刊出日期:  2024-09-10

目录

    /

    返回文章
    返回